4.8 Letter

Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Cell & Tissue Engineering

Toward the Development of a Global Induced Pluripotent Stem Cell Library

Marc Turner et al.

CELL STEM CELL (2013)

Review Cell & Tissue Engineering

Induced Pluripotent Stem Cells: Past, Present, and Future

Shinya Yamanaka

CELL STEM CELL (2012)

Review Cell & Tissue Engineering

Managing particulates in cellular therapy

Dominic Clarke et al.

CYTOTHERAPY (2012)

News Item Biotechnology & Applied Microbiology

Hemacord approval may foreshadow regulatory creep for HSC therapies

Malorye Allison

NATURE BIOTECHNOLOGY (2012)

Editorial Material Multidisciplinary Sciences

US Regulation of Stem Cells as Medical Products

Douglas Sipp et al.

SCIENCE (2012)

Article Cell & Tissue Engineering

Steering a New Course for Stem Cell Research: NIH's Intramural Center for Regenerative Medicine

Mahendra S. Rao et al.

STEM CELLS TRANSLATIONAL MEDICINE (2012)

Article Cell & Tissue Engineering

Specimen Collection for Induced Pluripotent Stem Cell Research: Harmonizing the Approach to Informed Consent

Justin Lowenthal et al.

STEM CELLS TRANSLATIONAL MEDICINE (2012)

Article Ethics

Translating Stem Cell Research: Challenges at the Research Frontier

David Magnus

JOURNAL OF LAW MEDICINE & ETHICS (2010)

Review Cell & Tissue Engineering

Human induced pluripotent stem cells: a review of the US patent landscape

Bilyana P. Georgieva et al.

REGENERATIVE MEDICINE (2010)

Article Cell & Tissue Engineering

Regulatory considerations for the development of autologous induced pluripotent stem cell therapies

Melissa K. Carpenter et al.

REGENERATIVE MEDICINE (2010)

Article Cell & Tissue Engineering

Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead

Lars Ahrlund-Richter et al.

CELL STEM CELL (2009)